23rd Human Proteome Organization World Congress

Deep proteomic profiling of matched CSF and plasma samples for aging biomarker discovery beyond protein

Human Health Insights (Neurobiology, Cardiovascular, Liver, Kidney etc.)

Poster presentation

Simultaneous targeted and discovery-driven clinical proteotyping using hybrid-PRM/DIA

Clinical Proteomics

Clinical Proteomics I

Digital proteome: a resource for target expression across 22 tissues in human and preclinical species

Data Integration: With Bioinformatics to Biological Knowledge

Significantly faster library-free dia-PASEF analysis with a Spectronaut integrated workflow in ProteoScape

Target identification, selectivity profiling and binding site mapping of small molecule and peptide drugs by LiP-MS

Chemical Biology Insights

High-throughput and deep plasma proteomics allows the classification of cancer types

Proteomics in medicine and clinical research

Oral presentation

Advancements in LiP-MS: short-gradient LC-MS and automated sample preparation for improved drug target identification

Structural Proteomics

A systematic optimization of diagonal-PASEF acquisition for low- to medium-input acquisitions on the timsTOF HT mass spectrometer

New Technology: MS-based Proteomics

Facilitating large-scale proteomics by combining automated sample preparation with short gradient LC-MS acquisitions

Population Proteomics in Health and Disease

Input normalization and PTM stoichiometry calculations in Spectronaut®

The view from CRO land – How pharma/biotech uses proteomics

Aims
<ol>
<li>Outline the increasingly important role of the HUPO community in drug discovery</li>
<li>Highlight opportunities for academic-industry partnership at the interface of CPDD.</li>
<li>Lay a strategic roadmap/Discuss key priorities for a HUPO Initiative on CPDD.</li>
</ol>

Conference room 3-4

Chemical proteomics and drug discovery

Pre-congress workshop

Pre-congress lecture

Pre-congress speaker

Advancing DIA data processing: pushing the boundaries and tackling current field challenges

In the modern landscape of mass spectrometry proteomics, bioinformatics has become a cornerstone for generating, managing, and interpreting data efficiently and effectively. Our lunch seminar will delve into this critical aspect, showcasing how scalable bioinformatics solutions can prevent data analysis bottlenecks and ensure rapid, versatile results. Hear from our head of research for Bruker ProteoScape™ (BPS), Jonathan Krieger Ph.D., about our strategies to provide impactful solutions, followed by an insightful talk on rescoring MS2 data to maximize its value by members of the CompOmics group run by Prof. Lennart Martens at the University of Ghent. Finally, we will join Lukas Reiter, Ph.D., CTO at Biognosys, to discover the enhanced capabilities of Spectronaut 19, specifically optimized for timsTOF data, and see how it can elevate your proteomics research.&nbsp;Don't miss this opportunity to learn how advanced bioinformatics can influence your project's success.

Bruker

Maximize the Potential of Your Data: Scalable Bioinformatics to Access Meaningful Results

Industry symposium

Industry lecture

Industry speaker

Lukas Reiter

Pre-congress speaker

Industry speaker

Further involvements